HealthDay - TUESDAY, Jan. 18 (HealthDay News) -- A genetic test seems able to identify which people with stage II colon cancer face a higher risk of recurrence, German researchers report.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.